While in some studies metformin treatment increased APP27 or Aβ levels24, other studies showed that metformin attenuated AD-like neuropathology for example by decreasing the level of the APP processing enzyme BACE115, or by decreasing tau hyperphosphorylation7,25. The gene discussed is MAPT; the disease is Alzheimer disease.